ufp technologies announces results of annual stockholder meeting

UFP Technologies , Inc. (NASDAQ:UFPT), a specialty manufacturer with a market capitalization of $1.91 billion and impressive revenue growth of 34% in the last twelve months, held its Annual Meeting of Stockholders on June 4, 2025, according to a recent SEC filing. The meeting included several key votes on corporate governance matters. According to InvestingPro analysis, the company maintains a "GREAT" financial health score, supported by strong profitability metrics and solid balance sheet management.

Stockholders elected seven directors to serve until the 2026 Annual Meeting. The elected directors are R. Jeffrey Bailly, Thomas Oberdorf, Marc Kozin, Daniel C. Croteau, Cynthia L. Feldmann, Joseph John Hassett, and Symeria Hudson (NYSE:HUD). Each candidate received a majority of votes in favor. With a current ratio of 2.58 and moderate debt levels, the company’s strong financial position suggests effective board oversight.

An advisory vote on executive compensation was also held, with the majority of stockholders approving the compensation package as outlined in the company’s proxy statement. The vote was non-binding.

Additionally, stockholders voted on the frequency of future advisory votes on executive compensation. The majority supported holding these votes annually, with 5,996,792 votes in favor of a one-year frequency.

The appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified by the stockholders. The proposal received 6,445,924 votes in favor.

The decisions made during this meeting were based on the information provided in the company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 30, 2025. For investors seeking deeper insights, InvestingPro offers comprehensive analysis with 10 key investment tips and detailed financial metrics, available in the Pro Research Report covering UFPT among 1,400+ top US stocks.

In other recent news, UFP Technologies Inc. reported a strong performance in the first quarter of 2025, with revenue increasing by 41% to $148.1 million, surpassing the anticipated $140.1 million. The company’s adjusted earnings per share (EPS) also exceeded expectations, reaching $2.47 against a forecast of $2.00. This impressive growth was largely driven by a 50.4% rise in medical market sales, highlighting the company’s robust position in the medical technology sector. Additionally, UFP Technologies’ strategic acquisitions have been significant contributors to its growth, with the recent acquisition of AJR showing a notable increase in revenue. The company has also been actively pursuing new product developments and acquisitions, which are expected to support ongoing expansion. Furthermore, UFP Technologies is optimistic about future growth, with new robotic surgery programs and product developments in infection prevention and surgical segments on the horizon. Analyst firms, such as Lake Street and KeyBanc, have shown interest in the company’s growth trajectory and strategic initiatives. UFP Technologies continues to focus on expanding its business in growth markets and exploring strategic acquisitions to enhance its value to customers.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.